Eric P. Lefkofsky Sells 562,345 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 562,345 shares of Tempus AI stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $50.93, for a total value of $28,640,230.85. Following the sale, the chief executive officer now directly owns 9,457,283 shares in the company, valued at $481,659,423.19. The trade was a 5.61 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Tempus AI Trading Up 0.5 %

NASDAQ TEM opened at $49.10 on Friday. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The business has a 50 day moving average price of $54.30 and a 200-day moving average price of $52.44. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Analysts Set New Price Targets

A number of brokerages have recently commented on TEM. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and lifted their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Guggenheim restated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. Bank of America raised their price objective on Tempus AI from $54.00 to $60.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. Finally, Piper Sandler lowered their price objective on Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Tempus AI currently has a consensus rating of “Moderate Buy” and a consensus price target of $61.18.

Institutional Investors Weigh In On Tempus AI

Hedge funds and other institutional investors have recently modified their holdings of the company. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI during the third quarter valued at approximately $30,000. Operose Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter valued at approximately $25,000. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter valued at approximately $34,000. Prestige Wealth Management Group LLC increased its holdings in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after acquiring an additional 965 shares in the last quarter. Finally, NewEdge Advisors LLC bought a new stake in shares of Tempus AI during the fourth quarter valued at approximately $49,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.